Quick Search
  Home Journal Information Current Issue Past Issues Services Contact Us  
Articles
Prevention of metabolic decompensation in an infant with mutase deficient methylmalonic aciduria undergoing cardiopulmonary bypass 
 
Prevention of metabolic decompensation in an infant with mutase deficient methylmalonic aciduria undergoing cardiopulmonary bypass
  Raymond Y Wang, Richard C Chang, Mary E Sowa, Anthony C Chang, Jose E Abdenur
 [Abstract] [Full Text] [PDF]   Pageviews: 9643 Times
   

Prevention of metabolic decompensation in an infant with mutase deficient methylmalonic aciduria undergoing cardiopulmonary bypass

Raymond Y Wang, Richard C Chang, Mary E Sowa, Anthony C Chang, Jose E Abdenur

Orange, CA, USA

Author Affiliations: Division of Metabolic Disorders, CHOC Children's Foundation, Department of Pediatrics, University of California Irvine School of Medicine, Orange, CA, USA (Wang RY, Chang RC, Abdenur JE); Department of Clinical Nutrition and Lactation, CHOC Children's, Orange, CA, USA (Sowa ME); Division of Cardiology, Pediatric Subspecialty Faculty, Heart Institute, CHOC Children's, Orange, CA, USA (Chang AC)

Corresponding Author: Raymond Y Wang, MD, Division of Metabolic Disorders, CHOC Children's, 1201 W. La Veta Ave, Orange 92868, CA, USA (Tel: 714-509-8852; Fax: 714-509-3921; Email: rawang@choc.org)

doi: 10.1007/s12519-014-0458-0

Background: Effects of circulatory arrest upon an inborn error of metabolism patient are unknown.

Methods: A retrospective chart review was performed of outcome and biochemical parameters obtained during palliative cardiac surgery for a mutase-deficient methylmalonic aciduria patient with Ebstein's cardiac anomaly was performed.

Results: The levels of ammonia, methylmalonic acid, free carnitine, and propionylcarnitine of the patient were improved. The patient survived surgery following institution of four metabolic treatment principles: 1) restriction of toxic substrate; 2) promotion of anabolism via administration of carbohydrate and lipid calories; 3) administration of detoxifying levocarnitine and sodium benzoate; and 4) cobalamin enzymatic co-factor administration. The patient died from post-operative dysrhythmia and was posthumously determined to have compound heterozygosity for mutations predicting severe, cobalamin non-responsive disease: c.322C>T/c.1233del3 (p.R108C/p.¦¤I412).

Conclusion: Metabolic decompensation is preventable during cardiopulmonary bypass and cardioplegia using four principles of metabolic treatment.

Key words: bypass; management; methylmalonic aciduria

World J Pediatr 2014;10(1):83-85

 

 
  [Articles Comment]

  title Author The End Revert Time Revert / Count

  Username:
  Comment Title: 
 
   

 

     
 
     
World Journal of Pediatric Surgery

roger vivier bags 美女 美女

Home  |  Journal Information  |  Current Issue  |  Past Issues  |  Journal Information  |  Contact Us
Children's Hospital, Zhejiang University School of Medicine, China
Copyright 2007  www.wjpch.com  All Rights Reserved Designed by eb